close
Add to watchlist
NMT Medical Inc (NMTI) Healthcare, Medical Equipment & Supplies
NMT Medical, Inc., a medical technology company, designs, develops, manufactures, and markets implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive catheter-based procedures. Its products primarily include CardioSEAL, a cardiac septal repair implant device used for the repair of structural heart disease and intracardiac shunts that result in abnormal blood flow through the chambers of the heart; STARFlex, which incorporates a self-centering system that allows the implant to self-adjust to variations in the anatomy of a septal defect without deforming the septum or interfering with heart valve function; and BioSTAR, a bioabsorbable PFO implant and biological closure technology. The company also develops BioTREK, a biological closure technology, which incorporates a biosynthetic material that uses the body's own regenerative capability to restore function naturally. Its customers include hospitals, clinics, and other healthcare centers. The company markets its products through distributors, as well as directly in the United States, Canada, Europe, and internationally. NMT Medical, Inc. was founded in 1986 and is headquartered in Boston, Massachusetts.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 0.23 |
| Volume | 570130 |
| Volume Avg | 254617 |
| 52 Week High | 4.99 |
| 52 Week Low | 0.20 |
| PE | N/A |
| PE (group average) | 39 |
| EPS Year | -0.71 |
| EPS change Q/Q | -1000% |
| EPS change Q/Q Yr ago | -1000% |
| EPS change Q/Q next Q est | -100% |
| EPS change Y/Y | -64% |
| REV change Q/Q | -13.33% |
| REV change Q/Q Yr ago | -18.75% |
| EPS next Q est | 0.00 |
| EPS next Y est | 0.00 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |